Research progress on the pathogenesis of diabetic peripheral neuropathy

doi:10.3877/cma.j.issn.2095-123X.2019.03.012

Abstract

Abstract:

Diabetic peripheral neuropathy (DPN), as the most common complication of diabetes mellitus, is manifested in peripheral nerve dysfunction to a certain extent, affecting the quality of life of patients. Based on the research on the pathogenesis of DPN at home and abroad in recent years, this paper reviews the pathogenesis of DPN in the aspects of metabolism, immunity, genes and hypoglycemic drugs, so as to provide ideas for the research and treatment of DPN mechanism in the future.

Key words: Diabetic peripheral neuropathy, Pathogenesis, Immunity, Genetics, Hypoglycemic drugs

Hailun Huang, Shan Wu. Research progress on the pathogenesis of diabetic peripheral neuropathy[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2019, 09(03): 176-180.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnkjbykfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-123X.2019.03.012

https://zhnkjbykfzz.cma-cmc.com.cn/EN/Y2019/V09/I03/176

References 45

[1]	Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98.
[2]	Shen X, Vaidya A, Wu S, et al. The diabetes epidemic in China: an integrated review of national surveys[J]. Endocr Pract, 2016, 22(9): 1119-1129.
[3]	Sztanek F, Molnárné Molnár á, Balogh Z. The role of oxidative stress in the development of diabetic neuropathy[J]. Orv Hetil, 2016, 157(49): 1939-1946.
[4]	Ferland-McCollough D, Slater S, Richard J, et al. Pericytes, an overlooked player in vascular pathobiology[J]. Pharmacol Ther, 2017, 171: 30-42.
[5]	施丽丽，任明山，吴元洁,等.线粒体分裂蛋白Drp-1参与糖尿病周围神经病发病的机制[J].中华医学杂志, 2012, 92(21): 1502-1504.
[6]	Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives[J]. Oxid Med Cell Longev, 2013, 2013: 168039.
[7]	de la Hoz CL, Cheng C, Fernyhough P, et al. A model of chronic diabetic polyneuropathy: benefits from intranasal insulin are modified by sex and RAGE deletion[J]. Am J Physiol Endocrinol Metab, 2017, 312(5): E407-E419.
[8]	Saleh A, Smith DR, Tessler L, et al. Receptor for advanced glycation end-product（sRAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons[J]. Exp Neurol, 2013, 249: 149-159.
[9]	Jamwal S, Sharma S. Vascular endothelium dysfunction: a conservative target in metabolic disorders[J]. Inflamm Res, 2018, 67(5): 391-405.
[10]	Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome[J]. J Diabetes Investig, 2017, 8(5): 646-655.
[11]	施丽丽，任明山，吴元洁.糖尿病周围神经病变与氧化应激研究现状[J].安徽医科大学学报, 2012, 47(1): 94-96.
[12]	秦宏超，张真稳. 2型糖尿病周围神经病变患者外周血CD4⁺调节性T细胞与25-(OH)D3的关系及其意义[J].中国现代医学杂志, 2018, 28(18): 45-49.
[13]	董荣芳，张铭，郑丹枫,等.糖尿病周围神经病的病理学研究[J].诊断病理学杂志, 2015, 22(3): 133-138.
[14]	Rachana KS, Manu MS, Advirao GM. Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy[J]. Neurosci Lett, 2016, 629: 110-115.
[15]	Tang W, Lv Q, Zou JJ, et al. CD8(+) T cell-mediated cytotoxicity toward Schwann cells promotes diabetic peripheral neuropathy[J]. Cell Physiol Biochem, 2013, 32(4): 827-837.
[16]	Hong J, Tobin NP, Rundqvist H, et al. Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells[J]. J Natl Cancer Inst, 2015, 107(10): pii djv209.
[17]	Sohail MU, Asmaa A, Haseeb A, et al. Role of the gastrointestinal tract microbiome in the pathophysiology of diabetes mellitus[J]. J Diabetes Res, 2017, 2017: 9631435.
[18]	Oellgaard J, Winther SA, Hansen TS, et al. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des, 2017, 23(25): 3699-3712.
[19]	Perez-Matos MC, Morales-Alvarez MC, Mendivil CO. Lipids: a suitable therapeutic target in diabetic neuropathy?[J]. J Diabetes Res, 2017, 2017: 6943851.
[20]	陈致瑜，刘率男，刘泉,等.阿托伐他汀对糖耐量异常KKAy小鼠胰岛功能的影响及初步机制探讨[J].中国临床药理学杂志, 2014, 30(9): 783-787.
[21]	张春雪，王燕，郑晓岩,等.二甲双胍对2型糖尿病大鼠胆固醇代谢途径的影响[J].中国老年学杂志, 2017, 37(21): 5238-5240.
[22]	El-Horany HE, Watany MM, Hagag RY, et al. Expression of LRP1 and CHOP genes associated with peripheral neuropathy in type 2 diabetes mellitus: correlations with nerve conduction studies[J]. Gene, 2019, 702: 114-122.
[23]	Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury[J]. Prog Neurobiol, 2019, 173: 102-121.
[24]	Wang X, Chen Q, Yi S, et al. The microRNAs let-7 and miR-9 down-regulate the axon-guidance genes Ntn1 and Dcc during peripheral nerve regeneration[J]. J Biol Chem, 2019, 294(10): 3489-3500.
[25]	Cheng C, Kobayashi M, Martinez JA, et al. Evidence for epigenetic regulation of gene expression and function in chronic experimental diabetic neuropathy[J]. J Neuropathol Exp Neurol, 2015, 74(8): 804-817.
[26]	Liu XS, Fan B, Szalad A, et al. MicroRNA-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice[J]. Diabetes, 2017, 66(12): 3111-3121.
[27]	Zhang Y, Song C, Liu J, et al. Inhibition of miR-25 aggravates diabetic peripheral neuropathy[J]. Neuroreport, 2018, 29(11): 945-953.
[28]	Chang YS, Kan HW, Hsieh YL. Activating transcription factor 3 modulates protein kinase C epsilon activation in diabetic peripheral neuropathy[J]. J Pain Res, 2019, 12: 317-326.
[29]	Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial[J]. Lancet, 2010, 376(9739): 419-430.
[30]	Sahin M, Tutuncu NB, Ertugrul D, et al. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus[J]. J Diabetes Complications, 2007, 21(2): 118-123.
[31]	王军文，史耐云，陈卫.巨幼细胞贫血伴随维生素B12和(或)叶酸增高的诊断分析[J].国际检验医学杂志, 2013, 34(4): 510.
[32]	Gupta K, Jain N, Rohatgi A. An observational study of vitamin B12 levels and peripheral neuropathy profile in patients of diabetes mellitus on metformin therapy[J]. Diabetes Metab Syndr, 2018, 12(1): 51-58.
[33]	Jayabalan B, Low LL. Vitamin B supplementation for diabetic peripheral neuropathy[J]. S Singapore Med J, 2016, 57(2): 55-59.
[34]	孙丽艳，赵蒙，殷宏宇,等.两种降糖方式对糖尿病周围神经病患者F波的影响及意义[J].中国实验诊断学, 2017, 21(5): 810-813.
[35]	Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats[J]. J Nutr, 1999, 129(1): 207-213.
[36]	Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology[J]. Neurology, 2003, 60(6): 898-904.
[37]	潘映辐.临床诱发电位学[M].第2版.北京:人民卫生出版社, 2000: 165-168.
[38]	American Diabetes Association. Diabetes advocacy: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S182-S183.
[39]	Ozaki K, Yamano S, Matsuura T, et al. Insulin-ameliorated peripheral motor neuropathy in spontaneously diabetic WBN/Kob rats[J]. J Vet Med Sci, 2013, 75(10): 1323-1328.
[40]	Dandona P, Mohanty P, Chaudhuri A, et al. Insulin infusion in acute illness[J]. J Clin Invest, 2005, 115(8): 2069-2072.
[41]	Koike H, Takahashi M, Ohyama K, et al. Clinicopathologic features of folate-deficiency neuropathy[J]. Neurology, 2015, 84(10): 1026-1033.
[42]	Mottaghi T, Khorvash F, Maracy M, et al. Effect of folic acid supplementation on nerve conduction velocity in diabetic polyneuropathy patients[J]. Neurol Res, 2019, 41(4): 364-368.
[43]	Meng X, Maurel P, Lam I, et al. Necl-4/Cadm4 recruits Par-3 to the Schwann cell adaxonal membrane[J]. Glia, 2019, 67(5): 884-895.
[44]	Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy[J]. J Neurosci Res, 1990, 26(2): 258-267.
[45]	Cheng HT, Dauch JR, Hayes JM, et al. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes[J]. Neurobiol Dis, 2012, 45(1): 280-287.

Please choose a citation manager

Content to export